Lekzipine® 0,2 g №50

 

Group of action: Agents affecting the nervous system

Active ingredient: Carbamazepine

Dosage form: Tablets

Pharmacotherapeutic group: Antiepileptics. Carbamazepine.

ATC code: N03AF01

RX/OTC: RX

 

Indications   Epilepsy and complex or simple partial seizures (with loss or without loss of consciousness) with secondary generalization or without it; generalized tonic-clonic seizures. Mixed forms of seizures. carbamazepine can be used as monotherapy or in combination therapy. Acute mania and maintenance treatment of bipolar affective disorders to prevent relapse or exacerbation of clinical manifestations of weakening. The syndrome alcohol withdrawal. Idiopathic trigeminal neuralgia and trigeminal neuralgia in multiple sclerosis (typical and atypical). Idiopathic neuralgia glossopharyngeal nerve. Diabetic neuropathy with pain. Diabetes insipidus of central genesis. Polyuria and polydipsia of neurohormonal nature.
Contraindications  

Do not use the drug:

  • when determined the hypersensitivity to carbamazepine or chemically similar to drugs (eg tricyclic antidepressants) or any other component of the product;
  • with atrioventricular block;
  • in patients with bone marrow depression in history;
  • in patients with hepatic porphyria (acute example of intermittent porphyria, a mixed porphyria, late skin porphyria) in history;
  • for acute liver failure; in combination with monoamine oxidase inhibitors (MAOI);
  • children under 6 years.
Basic physical and chemical properties   Single-layer tablet of round shape, with a flat top and bottom surfaces, the edges of which are chamfered, with mark, white or white with a yellowish tinge. At fault when viewed under a magnifying glass can be seen relatively homogeneous structure.
Shelf life   3 years
Storage conditions   Keep in original packaging at temperature not exceeding 25 ° С. Keep out of reach of children.